Patents by Inventor Paul M. Gargiulo

Paul M. Gargiulo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal Therapeutic System
    Publication number: 20130266633
    Abstract: The present invention relates to Transdermal Therapeutic Systems having a silicone adhesive layer, to Transdermal Therapeutic Systems providing specific plasma concentrations, to their manufacture and use.
    Type: Application
    Filed: May 31, 2013
    Publication date: October 10, 2013
    Applicant: Novartis AG
    Inventors: Paul M. Gargiulo, Roger Michael Lane, Beatrix Platt, Frank Theobald, Bettina Wall
  • TTS containing an antioxidant
    Patent number: 6335031
    Abstract: Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an anti-oxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: January 1, 2002
    Assignees: Novartis AG, LTS Lohmann Therapie-Systeme GmbH Co. KG
    Inventors: Bodo Asmussen, Michael Horstmann, Kai Köpke, Henricus L. G. M. Tiemessen, Steven Minh Dinh, Paul M. Gargiulo
  • TTS containing an antioxidant
    Publication number: 20010048938
    Abstract: Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an anti-oxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.
    Type: Application
    Filed: December 20, 2000
    Publication date: December 6, 2001
    Inventors: Bodo Asmussen, Michael Horstmann, Kai Kopke, Henricus L.G.M. Tiemessen, Steven Minh Dinh, Paul M. Gargiulo
  • TTS containing an antioxidant
    Patent number: 6316023
    Abstract: Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an antioxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: November 13, 2001
    Assignees: Novartis AG, LTS Lohmann Therapie-Systeme GmbH
    Inventors: Bodo Asmussen, Michael Horstmann, Kai Köpke, Henricus L. G. M. Tiemessen, Steven Minh Dinh, Paul M. Gargiulo